Live Breaking News & Updates on Epileptic

Stay updated with breaking news from Epileptic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Study reveals how CBD counters epileptic seizures

A new study illustrates how cannabidiol (CBD), a chemical present in cannabis, decreases seizures in several treatment-resistant forms of paediatric epilepsy. ....

Evan-rosenberg , Richardw-tsien , Langone-health , Grossman-school-of-medicine , Department-of-physiology , Study , Eveals , Dow , Bd , Counters , Epileptic , Seizures

Transcripts for FOXNEWS The Ingraham Angle 20240604 03:50:00

Medical marijuana. people like the families that are picking up and moving to states that permit medical marijuana to get their therapeutic use to access to marijuana that can reduce the violent epileptic seize uros that torture seizures that torture their children. laura: he stopped inhaling and advocates for legalization and recently admitted to politico, i want to keep this out of the hands of young people. this is for the developing mind. no kidding. we ve been saying this for years and years and years, the science has been here for years and he must be watching the show. study after study demonstrated how marijuana use cannot only cause depression and psychosis but it s incredibly dangerous for brains that have not yet matured. joining me now is luke, executive vice president of smart approaches to marijuana. ....

People , Marijuana , States , Use , Families , Laura-ingraham , Children , Marijuana-legalization , Seizures , Torture , Epileptic , Euros

Eisai to Divest Rights for Anti-Epileptic Drug Fycompa (perampanel) CIII in United States to Catalyst Pharmaceuticals

TOKYO, Dec 20, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the United States (U.S.) commercial rights for the anti-epileptic drug (AED) Fycompa ....

Tokyo , Japan , United-states , Canada , Christopher-vancheri , Catalyst-pharmaceuticals , Eisai-inc , Eisai-co-ltd , Us-food-drug-administration , Catalyst-pharmaceuticals-inc , Global-health , Public-relations-department

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals will unveil its wearable healthcare devices at the upcoming Consumer Electronics Show (CES) next month as part of its plan to advance into the digital healthcare business, its head of R&D said Wednesday. “The bio industry is changing by converging with ICT. We believe there will be a patient-centric period in the bio industry and we will try to lead the trend with our digital healthcare technology,” Hwang Sun-gwan, vice president of SK Biopharmaceuticals R&D Innovation, said during a press conference in Seoul. ....

Seoul , Soult-ukpyolsi , South-korea , Baek-byung-yeul , Hwang-sun-gwan , Las-vegas , Koreana-hotel , Consumer-electronics-show , Hwang-sung-gwan , Zero-glasses , Zero-wired , Zero-headband

DelveInsight Business Research, LLP: Developmental and Epileptic Encephalopathy Market to Exhibit Growth at a Remarkable CAGR of 15.5% During the Forecast Period (2022-2032)

The dynamics of developmental and epileptic encephalopathy (DEE) market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness ....

Germany , Italy , Japan , United-states , United-kingdom , France , Spain , Shruti-thakur , Neurocrine-biosciences , Afinitor-votubia-everolimus , Diacomit-biocodex , Fintepla-zogenix